A Comparative Study of Effects of Ateloollagen Injection and Platelet-Rich Plasma Injection in Patients with Lateral Epicondylitis

A Comparative Study of Effects of Ateloollagen Injection and Platelet-Rich Plasma Injection in Patients with Lateral Epicondylitis : prospective randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0007912

Enrollment

Registered

2022-11-18

Start date

2022-11-01

Completion date

Unknown

Last updated

2022-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : The atelocollagen injection treatment group will use the commercialized atelocollagen (6% Regenseal 1cc, Sewon Cellontech), and for platelet-rich plasma injection treatment patients, the lead r

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Yeouido St. Mary's Hospital Orthopedic Surgery Outpatient 2) Adult men and women over 20 years of age as of the date of consent 3) Patients complaining of symptoms of elbow osteoarthritis and confirmed with partial rupture of the anterior tendon by MRI 4) Those who understand the research and can voluntarily consent

Exclusion criteria

Exclusion criteria: 1) In case of other diseases that cause elbow joint pain other than traumatic perfortitis on MRI (fracture, infection, neuropathy, internal epicondylitis, arthritis, etc.) 2) Patient unable to communicate 3) Patients with poor understanding of the purpose and method of the experiment

Design outcomes

Primary

Measure	Time frame
Range of motion	—

Secondary

Measure	Time frame
Patient-rated elbow lateral epicondylitis score;Structural recovery of the ruptured tendon	—

Countries

Korea, Republic of

Contacts

Public ContactJong Ho Kim

The Catholic University of Korea, Yeouido St. Mary's Hospital

katris@naver.com+82-2-3776-2166

Outcome results